131 related articles for article (PubMed ID: 981971)
1. Immune complexes in human melanoma: a consequence of deranged immune regulation.
Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
[TBL] [Abstract][Full Text] [Related]
2. Serial determinations of melanoma tumor-associated antigen and antibody in patients with stage I melanoma.
Wong JH; Gupta RK; Morton DL
Arch Surg; 1986 Nov; 121(11):1342-5. PubMed ID: 3778209
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complexes in malignant melanoma.
Gupta RK
Dis Markers; 1988 Jun; 6(2):81-95. PubMed ID: 3042263
[No Abstract] [Full Text] [Related]
4. Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms.
Queen WD; Bharwani N; Phillips EA; Ruether BA; Phillips TM; Jerry LM
Oncology; 1989; 46(1):14-25. PubMed ID: 2915889
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in human malignant melanoma.
D'Amelio R; Cooke B; Hobbs JR
Tumori; 1982 Dec; 68(6):469-72. PubMed ID: 7168010
[TBL] [Abstract][Full Text] [Related]
6. Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.
Gupta RK; Leitch AM; Morton DL
Cancer Immunol Immunother; 1983; 16(1):40-7. PubMed ID: 6556950
[TBL] [Abstract][Full Text] [Related]
7. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
[TBL] [Abstract][Full Text] [Related]
9. Circulating immune complexes in patients with neoplastic disorders.
Yoshida R; Zawadzki ZA
Oncology; 1980; 37(3):152-6. PubMed ID: 7360487
[TBL] [Abstract][Full Text] [Related]
10. Immune derangement in patients with malignant melanoma.
Lewis MG; Phillips TM; Noble PB; Hartmann DP
J Cutan Pathol; 1979 Jun; 6(3):201-7. PubMed ID: 479438
[TBL] [Abstract][Full Text] [Related]
11. Xenogeneic oncofetal antigen reexpressed in human neoplasia.
Salinas FA; Wee KH
Ann N Y Acad Sci; 1980; 349():409-10. PubMed ID: 6939372
[No Abstract] [Full Text] [Related]
12. Renal deposition of soluble immune complexes in mice bearing B-16 melanoma. Characterization of complexes and relationship to tumor progress.
Poskitt PK; Poskitt TR; Wallace JH
J Exp Med; 1974 Aug; 140(2):410-25. PubMed ID: 4603012
[TBL] [Abstract][Full Text] [Related]
13. Endogenous immune complex nephropathy associated with malignancy I. Studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterization of tumor specific antigen and antibody and circulating immune complexes.
Ozawa T; Pluss R; Lacher J; Boedecker E; Guggenheim S; Hammond W; McIntosh R
Q J Med; 1975 Oct; 44(176):523-41. PubMed ID: 53850
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated antigen immune complexes. A potential marker of recurrent melanoma.
Wong JH; Xu SH; Gupta RK; Morton DL
Arch Surg; 1990 Feb; 125(2):187-91. PubMed ID: 2302059
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two 125I C1q binding tests to detect soluble immune complexes in serum of patients with malignant disease.
Shepherd PS
Clin Exp Immunol; 1979 May; 36(2):250-5. PubMed ID: 477028
[TBL] [Abstract][Full Text] [Related]
16. [Determination of circulating immune complexes: comparison between agglutination inhibition and C1Q precipitation in polyethylene-glycol-EDTA (author's transl)].
Vincent C; Revillard JP
Pathol Biol (Paris); 1978 Jan; 26(1):73-9. PubMed ID: 99716
[TBL] [Abstract][Full Text] [Related]
17. The C1q binding test for soluble immune complexes: clinical correlations obtained in patients with cancer.
Rossen RD; Reisberg MA; Hersh EM; Gutterman JU
J Natl Cancer Inst; 1977 May; 58(5):1205-15. PubMed ID: 323505
[TBL] [Abstract][Full Text] [Related]
18. [Circulating immune complexes in the serum of tumor patients].
Alvarez R; García Gómez A; Subiza JL; Domínguez J; Bootello A; Coll J
Rev Esp Oncol; 1982; 29(4):727-34. PubMed ID: 6927370
[TBL] [Abstract][Full Text] [Related]
19. Serological survey of normal humans for natural antibody to cell surface antigens of melanoma.
Houghton AN; Taormina MC; Ikeda H; Watanabe T; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4260-4. PubMed ID: 6933476
[TBL] [Abstract][Full Text] [Related]
20. Antibodies and anti-antibodies in human malignancy: an expression of deranged immune regulation.
Lewis MG; Hartman D; Jerry LM
Ann N Y Acad Sci; 1976; 276():316-27. PubMed ID: 1088385
[No Abstract] [Full Text] [Related]
[Next] [New Search]
